A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.
Conditions: Triple-negative Breast Cancer Interventions: Drug: ATRA; Drug: Toripalimab Sponsors: First Affiliated Hospital of Zhejiang University; Shanghai Longfine Biotechnology Co., Ltd.; TopAlliance Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Breast Cancer | Cancer | Cancer & Oncology | Hospitals | Oral Cancer | Research | Study